Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
European Heart Journal
|
August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Marco Metra, Eric Eichhorn, William T Abraham, et al.
Circulation
|
August 6, 2014
The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
Alice K Jacobs, Jeffrey L Anderson, Jonathan L Halperin, et al.
Lancet (London, England)
|
September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, et al.
Circulation. Heart Failure
|
August 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial
Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology
|
August 30, 2022
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Nature Medicine
|
December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
Nature Medicine
|
March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
Nature Medicine
|
August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
JAMA
|
December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial
Orly Vardeny, KyungMann Kim, Jacob A Udell, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 2, 2015
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Stephan D Fihn, James C Blankenship, Karen P Alexander, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
European Heart Journal
|
August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Marco Metra, Eric Eichhorn, William T Abraham, et al.
Circulation
|
August 6, 2014
The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
Alice K Jacobs, Jeffrey L Anderson, Jonathan L Halperin, et al.
Lancet (London, England)
|
September 13, 2016
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, et al.
Circulation. Heart Failure
|
August 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial
Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology
|
August 30, 2022
Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
Jonathan W Cunningham, Muthiah Vaduganathan, Brian L Claggett, et al.
Nature Medicine
|
December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
Nature Medicine
|
March 18, 2023
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial
Orly Vardeny, James C Fang, Akshay S Desai, et al.
Nature Medicine
|
August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
Pardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
JAMA
|
December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial
Orly Vardeny, KyungMann Kim, Jacob A Udell, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 2, 2015
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Stephan D Fihn, James C Blankenship, Karen P Alexander, et al.
Page
of 6